FDA Adverse Event Injury Summary report: N

COMP LK SCR 3.5HEX 4.75X40 ST

MDR report key: 9204395 · Received October 17, 2019

Report

Report Number
0001825034-2019-04714
Event Type
Injury
Date Received
October 17, 2019
Date of Event
September 26, 2019
Report Date
March 24, 2020
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWS
PMA / PMN Number
K132239
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

AS IT IS UNKNOWN WHICH OF THE PERIPHERAL SCREWS FRACTURED THIS DEVICE WILL BE INVESTIGATED ON MEDWATCH#: 0001825034-2019-04717. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: COMP RVS CNTRL 6.5X30MM ST/RST PN: 115396 LOT: 047530, COMP LK SCR 3.5HEX 4.75X15 ST PN: 180550 LOT : 699000, COMP LK SCR 3.5HEX 4.75X40 ST PN: 180555 LOT: 233830, COMP LK SCR 3.5HEX 4.75X20 ST PN: 180551 LOT: 207730, COMP RVRS 25MM BSPLT HA+ADPTR PN: 010000589 LOT: 111130, COMP RVSR SHLDR GLNSP +3 36MM PN: 115313 LOT: 239860, UNKNOWN TM STEM. REPORT SOURCE: FOREIGN REPORT SOURCE: (B)(6). CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. PRODUCT NOT RETURNED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT WAS REVISED DUE TO IMPLANT FRACTURE AND SUBSEQUENT IMPLANT MIGRATION. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
995954 COMP LK SCR 3.5HEX 4.75X40 ST SHOULDER, PROSTHESIS KWS ZIMMER BIOMET, INC. 233830

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R